The Histories and Cultures of Evidence Utilisation: The Cases of Medical Oncology and Haematology

Broom, A; Adams, J

The Histories and Cultures of Evidence Utilisation: The Cases of Medical Oncology and Haematology

Broom, A Adams, J

Permalink

Publisher:: Ashgate Publishing Limited
Publication Type:: Chapter
Citation:: Evidence-Based Healthcare in Context: Critical Social Science Perspectives, 2012, 1, pp. 97 - 114
Issue Date:: 2012-01

Closed Access

	Filename	Description	Size
	2011006331OK.pdf		4.52 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Broom, A	en_US
dc.contributor.author	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.contributor.editor	Broom, A	en_US
dc.contributor.editor	Adams, J https://orcid.org/0000-0002-9901-5717	en_US
dc.date.issued	2012-01	en_US
dc.identifier.citation	Evidence-Based Healthcare in Context: Critical Social Science Perspectives, 2012, 1, pp. 97 - 114	en_US
dc.identifier.isbn	978-0-7546-7981-3	en_US
dc.identifier.uri	http://hdl.handle.net/10453/17772
dc.description.abstract	As outlined in our introduction to this book, the idea of EBM or EBP for biomedical clinicians, is to apply the best evidence to the clinical condition the are presented with. However, while EBM may seem to be mere commonsense, in actuality, and partcularly in the context of specialties like medical oncology and haematology, it presents a plethora of ideological, epistemological and practical issues. We argue here that for oncology clinicians operating at a grassroots level there is often a disconnection between EBM (and processes of standardisation) and the actual character of contemporary oncological work (De Vries and Lemmens 2006). Furthermore, the very value judgements and subjectivities that often go unrecognised in an EBM framework are actually critically important skills in oncology and haematology practice (Tredaniel et al, 2005). In oncology such disjunctions are accentuated with the constant development of new interventions (Joannidis, Schmid and Lau 2000) combined with the ommpresent need to 'try new things' with potentially terminal patients where standard treatments do not work.	en_US
dc.publisher	Ashgate Publishing Limited	en_US
dc.relation.ispartof	Evidence-Based Healthcare in Context: Critical Social Science Perspectives	en_US
dc.title	The Histories and Cultures of Evidence Utilisation: The Cases of Medical Oncology and Haematology	en_US
dc.type	Chapter
utslib.location	Farnham, Surrey, UK	en_US
utslib.for	1110 Nursing	en_US
utslib.citation.edition	1	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.consider-herdc	true	en_US
pubs.edition	1	en_US
pubs.place-of-publication	Farnham, Surrey, UK	en_US

Abstract:

As outlined in our introduction to this book, the idea of EBM or EBP for biomedical clinicians, is to apply the best evidence to the clinical condition the are presented with. However, while EBM may seem to be mere commonsense, in actuality, and partcularly in the context of specialties like medical oncology and haematology, it presents a plethora of ideological, epistemological and practical issues. We argue here that for oncology clinicians operating at a grassroots level there is often a disconnection between EBM (and processes of standardisation) and the actual character of contemporary oncological work (De Vries and Lemmens 2006). Furthermore, the very value judgements and subjectivities that often go unrecognised in an EBM framework are actually critically important skills in oncology and haematology practice (Tredaniel et al, 2005). In oncology such disjunctions are accentuated with the constant development of new interventions (Joannidis, Schmid and Lau 2000) combined with the ommpresent need to 'try new things' with potentially terminal patients where standard treatments do not work.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/17772